US$ 24.57
fda approval status of cjc-1295 and ipamorelin / | Clinician-Reviewed Peptide Therapy fda approval status cjc 1295
Description
K.CottinV.DharR.DanoffS.FlahertyK

Organ ECP 27 (6), 546552

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

doi: 10.1016/j.tem.2015.12.001

What they did not do is test systemically injected IGF-1 LR3 in humans, and the leap from local transgene in a mouse to injected analog in a person is scientifically enormous and unsupported
